However, it is important to note that GLP-1 agonists are not suitable for everyone and may cause unwanted side effects
The standard approach involves: Starting at 2.5 mg weekly for at least four weeks Increasing by 2.5 mg increments at four-week intervals Delaying dose escalation if gastrointestinal symptoms are problematic Recognizing that slower titration, while extending the time to reach therapeutic doses, may improve long-term adherence Injection Technique Optimization can reduce local reactions: Rotating injection sites (abdomen, thigh, upper arm) Allowing the medication to reach room temperature before injection Using proper technique to minimize tissue trauma Hypoglycemia Prevention requires careful attention when tirzepatide is combined with other glucose-lowering medications
Mid-luteal progesterone testing through your doctor is the gold standard
"Patriots Sign Two Unrestricted Free Agents"
In select situations, preoperative GLP-1-RA discontinuation may be considered, with the caveat that it may result in perioperative hyperglycemia
The higher the level of glucose in the blood, the more glycated hemoglobin is formed, pointing to poor glucose control
